Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Moloney GP et al. | Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. | 2008 | Eur J Med Chem | pmid:17582659 |
Panagis G et al. | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. | 2008 | Curr Drug Abuse Rev | pmid:19630731 |
Snider NT et al. | The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18698000 |
Ortar G et al. | Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. | 2008 | Eur J Med Chem | pmid:17452063 |
Malvindi MA et al. | Rod-shaped nanocrystals elicit neuronal activity in vivo. | 2008 | Small | pmid:18844306 |
Xiong W et al. | Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. | 2008 | Mol. Pharmacol. | pmid:17993512 |
Hill MN et al. | Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. | 2008 | Hippocampus | pmid:18058925 |
Egertová M et al. | Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. | 2008 | J. Comp. Neurol. | pmid:18067139 |
Rossi C et al. | Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. | 2008 | Eur. J. Clin. Pharmacol. | pmid:18004553 |
Di Marzo V et al. | The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. | 2008 | Br. J. Pharmacol. | pmid:18223666 |
Simon GM and Cravatt BF | Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. | 2008 | J. Biol. Chem. | pmid:18227059 |
Burstein S | The elmiric acids: biologically active anandamide analogs. | 2008 | Neuropharmacology | pmid:18187165 |
Maccarrone M et al. | Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. | 2008 | Nat. Neurosci. | pmid:18204441 |
Paradisi A et al. | Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. | 2008 | J. Biol. Chem. | pmid:18165231 |
Jackson SN et al. | Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. | 2008 | Eur. J. Pharmacol. | pmid:18242598 |
Butt C et al. | Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. | 2008 | J. Neurochem. | pmid:18194436 |
Oddi S et al. | Evidence for the intracellular accumulation of anandamide in adiposomes. | 2008 | Cell. Mol. Life Sci. | pmid:18213445 |
Baldassano S et al. | Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. | 2008 | Eur. J. Pharmacol. | pmid:18234188 |
Moreira FA et al. | Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. | 2008 | Neuropharmacology | pmid:17709120 |
Gorzalka BB et al. | Endocannabinoid modulation of male rat sexual behavior. | 2008 | Psychopharmacology (Berl.) | pmid:17694389 |
Rueda-Orozco PE et al. | A potential function of endocannabinoids in the selection of a navigation strategy by rats. | 2008 | Psychopharmacology (Berl.) | pmid:17805517 |
Engeli S et al. | Peripheral endocannabinoid system activity in patients treated with sibutramine. | 2008 | Obesity (Silver Spring) | pmid:18356837 |
Kurtuncu M et al. | Effects of cocaine in 5-lipoxygenase-deficient mice. | 2008 | J Neural Transm | pmid:18327533 |
Habayeb OM et al. | Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. | 2008 | JAMA | pmid:18334688 |
Oláh M et al. | The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. | 2008 | Mol. Cell. Endocrinol. | pmid:18308464 |
Potvin S et al. | Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. | 2008 | J. Psychopharmacol. (Oxford) | pmid:18308802 |
Hill MN et al. | Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. | 2008 | Pharmacopsychiatry | pmid:18311684 |
Migliarini B and Carnevali O | Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. | 2008 | Mol. Cell. Endocrinol. | pmid:18342434 |
Wise LE et al. | Evaluation of fatty acid amides in the carrageenan-induced paw edema model. | 2008 | Neuropharmacology | pmid:17675189 |
De Oliveira Alvares L et al. | Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. | 2008 | Neurobiol Learn Mem | pmid:18342551 |
Palkovits M et al. | Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. | 2008 | Neuroscience | pmid:18343585 |
Fezza F et al. | Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. | 2008 | J. Lipid Res. | pmid:18316795 |
Gertsch J | Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system. | 2008 | Planta Med. | pmid:18275004 |
Gonçalves P et al. | Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells. | 2008 | Pharmacology | pmid:18431074 |
Evans RM et al. | Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. | 2008 | Br. J. Pharmacol. | pmid:18376419 |
Di Marzo V and Maccarrone M | FAAH and anandamide: is 2-AG really the odd one out? | 2008 | Trends Pharmacol. Sci. | pmid:18394720 |
Kaufmann I et al. | Anandamide and neutrophil function in patients with fibromyalgia. | 2008 | Psychoneuroendocrinology | pmid:18395993 |
Hegde VL et al. | Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. | 2008 | Mol. Pharmacol. | pmid:18388242 |
Solinas M et al. | The endocannabinoid system in brain reward processes. | 2008 | Br. J. Pharmacol. | pmid:18414385 |
Richardson D et al. | Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. | 2008 | Arthritis Res. Ther. | pmid:18416822 |
Farrell EK and Merkler DJ | Biosynthesis, degradation and pharmacological importance of the fatty acid amides. | 2008 | Drug Discov. Today | pmid:18598910 |
Terry G et al. | Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. | 2008 | Neuroimage | pmid:18456516 |
Engel MA et al. | Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. | 2008 | J. Physiol. Pharmacol. | pmid:19212003 |
Mallat A and Lotersztajn S | Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. | 2008 | Diabetes Metab. | pmid:19195630 |
Yang Z et al. | Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. | 2008 | Biochem. Pharmacol. | pmid:18755158 |
Yao F et al. | Development of novel tail-modified anandamide analogs. | 2008 | Bioorg. Med. Chem. Lett. | pmid:18723350 |
Di Marzo V | Endocannabinoids: synthesis and degradation. | 2008 | Rev. Physiol. Biochem. Pharmacol. | pmid:18481028 |
Pertwee RG | Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. | 2008 | Addict Biol | pmid:18482430 |
Rueda-Orozco PE et al. | Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. | 2008 | Neuropharmacology | pmid:18501388 |
Di Filippo M et al. | Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. | 2008 | J. Neurol. Neurosurg. Psychiatr. | pmid:18535023 |
Kase Y et al. | Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. | 2008 | Ther Apher Dial | pmid:18937720 |
Ashton JC et al. | Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. | 2008 | Curr. Med. Chem. | pmid:18537620 |
Njie YF et al. | N-arachidonylethanolamide-induced increase in aqueous humor outflow facility. | 2008 | Invest. Ophthalmol. Vis. Sci. | pmid:18539938 |
Wang J et al. | Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. | 2008 | J. Biochem. | pmid:18806270 |
Murillo-RodrÃguez E et al. | The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. | 2008 | Neuroscience | pmid:18822353 |
Feizi A et al. | The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. | 2008 | Exp. Toxicol. Pathol. | pmid:18571910 |
Woo DH et al. | Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). | 2008 | Mol Pain | pmid:18826653 |
DeMorrow S et al. | The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18832445 |
Bambico FR and Gobbi G | The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | 2008 | Expert Opin. Ther. Targets | pmid:18851692 |
Dembiński A et al. | Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. | 2008 | Eur. J. Pharmacol. | pmid:18593574 |
Stark K et al. | Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. | 2008 | FEBS J. | pmid:18549450 |
Khasabova IA et al. | A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. | 2008 | J. Neurosci. | pmid:18971457 |
Hill MN et al. | Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. | 2008 | J Neural Transm | pmid:18974922 |
Kamei J et al. | [Sensitization of cough sensitivity through activation of C-and/or Adelta fibers]. | 2008 | Nippon Yakurigaku Zasshi | pmid:18552444 |
Thors L et al. | Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. | 2008 | Br. J. Pharmacol. | pmid:18552875 |
Ellgren M et al. | Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. | 2008 | Eur Neuropsychopharmacol | pmid:18674887 |
Fowler CJ and Ghafouri N | Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? | 2008 | Pharmacol. Res. | pmid:18675915 |
Hashiguchi T et al. | Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. | 2008 | J Anesth | pmid:18685926 |
Lisboa SF et al. | Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. | 2008 | Eur. J. Pharmacol. | pmid:18691568 |
Currie S et al. | IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. | 2008 | J. Mol. Cell. Cardiol. | pmid:18692061 |
Turco MY et al. | High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. | 2008 | Hum. Reprod. | pmid:18614613 |
Maccarrone M | Anandamide as a marker of human disease. | 2008 | JAMA | pmid:18632539 |
Hill MN et al. | Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. | 2008 | J. Neurochem. | pmid:18643796 |
Kudo R and Hatake K | [Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. | 2008 | Nihon Arukoru Yakubutsu Igakkai Zasshi | pmid:18646646 |
Maione S et al. | Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. | 2008 | Br. J. Pharmacol. | pmid:18660824 |
Fowler CJ | "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. | 2008 | Curr. Pharm. Des. | pmid:18781976 |
McPartland JM et al. | Cannabimimetic effects modulated by cholinergic compounds. | 2008 | Addict Biol | pmid:18782385 |
Ferreri C et al. | Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation. | 2008 | Bioorg. Med. Chem. | pmid:18782671 |
Rácz I et al. | Anandamide effects on 5-HT(3) receptors in vivo. | 2008 | Eur. J. Pharmacol. | pmid:18775693 |
Neelands TR et al. | Elevated temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion neurons. | 2008 | Inflamm. Res. | pmid:18777111 |
Placzek EA et al. | Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. | 2008 | J. Neurochem. | pmid:18778304 |
Scherma M et al. | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18725543 |
Ho WS et al. | 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. | 2008 | Br. J. Pharmacol. | pmid:18695637 |
Woodward DF et al. | The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. | 2008 | Pharmacol. Ther. | pmid:18700152 |
Williams JL et al. | K+ channel inhibition modulates the biochemical and morphological differentiation of human placental cytotrophoblast cells in vitro. | 2008 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:18703414 |
Moezi L et al. | Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18703639 |
Nakata M and Yada T | Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors. | 2008 | Regul. Pept. | pmid:17884194 |
Astarita G et al. | Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. | 2008 | J. Lipid Res. | pmid:17957091 |
Qin N et al. | TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. | 2008 | J. Neurosci. | pmid:18550765 |
Lehtonen M et al. | Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. | 2008 | Chem. Biodivers. | pmid:19035572 |
DeMorrow S et al. | Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18096608 |
Bjursell M et al. | Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. | 2008 | Am. J. Physiol. Endocrinol. Metab. | pmid:18029443 |
Butler RK et al. | Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. | 2008 | Pain | pmid:19004548 |
Williams MA et al. | The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. | 2008 | J. Physiol. (Lond.) | pmid:18063665 |
Rubino T et al. | Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. | 2008 | Cereb. Cortex | pmid:17921459 |
Gyires K and Zádori Z | [Analysis of central mechanisms involved in gastric mucosal integrity]. | 2008 | Neuropsychopharmacol Hung | pmid:18956615 |
Justinova Z et al. | Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. | 2008 | Biol. Psychiatry | pmid:18814866 |
Muccioli GG and Stella N | An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. | 2008 | Anal. Biochem. | pmid:17981259 |
Thiemann G et al. | The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. | 2008 | Behav. Brain Res. | pmid:17988751 |
Correa F et al. | Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). | 2008 | Biochem. J. | pmid:17961121 |